Global and United States Checkpoint Inhibitors for Treating Cancer Market Research by Company, Type & Application 2013-2025
SUMMARY
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
Market Segment as follows:
By Type
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
Market Segment as follows:
By Type
- PD-1 inhibitors
- PD-L1 inhibitors
- CTLA-4 inhibitors
- Melanoma treatment
- Bladder cancer treatment
- Others
- Bristol-Myers Squibb(BMS)
- Merck
- Roche
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 PD-1 inhibitors
1.1.2.2 PD-L1 inhibitors
1.1.2.3 CTLA-4 inhibitors
1.1.3 Market by Application
1.1.3.1 Melanoma treatment
1.1.3.2 Bladder cancer treatment
1.1.3.3 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Bristol-Myers Squibb(BMS)
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Merck
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Roche
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 PD-1 inhibitors
1.1.2.2 PD-L1 inhibitors
1.1.2.3 CTLA-4 inhibitors
1.1.3 Market by Application
1.1.3.1 Melanoma treatment
1.1.3.2 Bladder cancer treatment
1.1.3.3 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 GLOBAL AND REGIONAL MARKET BY COMPANY
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 GLOBAL AND REGIONAL MARKET BY TYPE
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 GLOBAL AND REGIONAL MARKET BY APPLICATION
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 REGIONAL TRADE
5.1 Export
5.2 Import
6 KEY MANUFACTURERS
6.1 Bristol-Myers Squibb(BMS)
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Merck
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Roche
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 INDUSTRY UPSTREAM
7.1 Industry Chain
7.2 Raw Materials
8 MARKET ENVIRONMENT
8.1 SWOT
8.2 Porter's Five Forces
9 CONCLUSION
LIST OF TABLES
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of Roche
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of Roche
LIST OF FIGURES
Figure PD-1 inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure PD-1 inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure PD-1 inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure PD-1 inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure PD-L1 inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure PD-L1 inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure PD-L1 inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure PD-L1 inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure CTLA-4 inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure CTLA-4 inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure CTLA-4 inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure CTLA-4 inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure Melanoma treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Melanoma treatment Market Size and CAGR 2013-2017 (Volume)
Figure Melanoma treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Melanoma treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Bladder cancer treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Bladder cancer treatment Market Size and CAGR 2013-2017 (Volume)
Figure Bladder cancer treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Bladder cancer treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Million USD)
Figure United States Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Volume)
Figure United States Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Checkpoint Inhibitors for Treating Cancer SWOT List
Figure Healthcare & Medical Porter's Five Forces
Figure PD-1 inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure PD-1 inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure PD-1 inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure PD-1 inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure PD-L1 inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure PD-L1 inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure PD-L1 inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure PD-L1 inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure CTLA-4 inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure CTLA-4 inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure CTLA-4 inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Figure CTLA-4 inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Figure Melanoma treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Melanoma treatment Market Size and CAGR 2013-2017 (Volume)
Figure Melanoma treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Melanoma treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Bladder cancer treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Bladder cancer treatment Market Size and CAGR 2013-2017 (Volume)
Figure Bladder cancer treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Bladder cancer treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Volume)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Million USD)
Figure United States Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2013-2017 (Volume)
Figure United States Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Checkpoint Inhibitors for Treating Cancer SWOT List
Figure Healthcare & Medical Porter's Five Forces
